-
Five Clinical Studies to Receive $2.5 Million Under Foundation’s 2007 Clinical Discovery Program
December 4, 2007
… common and debilitating aspects of PD such as depression, dyskinesia (the uncontrollable movements that are a side … that serotonin neurons are responsible for levodopa-induced dyskinesias. Using an advanced medical imaging technique, … a drug targeting a specific serotonin receptor decreases dyskinesias. Under a previous MJFF award, Anders Björklund, …
-
Promising Parkinson's Disease Research Highlighted by The Michael J. Fox Foundation to Accelerate Drug Development
August 12, 2014
… ultrasound as a noninvasive approach for the treatment of dyskinesia, a side effect of long-time use of PD drug … volume of tissue near the center of the brain can reduce dyskinesia, but typically requires surgery or a high dose of …
-
Michael J. Fox Foundation Awards $3.8 Million to Drive Nine Industry Partnerships for Pre-Clinical Parkinson's Drug Development
July 21, 2009
… receptor compounds on treatment of levodopa-induced dyskinesia in Parkinson’s disease Kristen Jordan, PhD, … of MOR antagonists for the treatment of L-DOPA-induced dyskinesias in Parkinson’s disease Patrick Little, PhD, …
-
Rytary (levodopa/carbidopa)
… medications like Rytary, long-term complications, such as dyskinesia, may be lessened. For those who have difficulty … (These are the same with all levodopa drugs.) Dyskinesia (involuntary, uncontrolled movements) also may …
-
Ask the MD: Latest in Levodopa Therapies
May 6, 2015
… dose, and levodopa use can cause side effects such as dyskinesia . Rachel Dolhun, MD, a movement disorders …
-
Maryka Quik, PhD
… that are responsible for the involuntary movements or dyskinesias that are a major complication of long-term …